04/27/2024
The ATLANTIS Study: A study in patients between 35 and 80 with Parkinson’s disease (diagnosed at least 5 years ago) is enrolling now.
We’re conducting a study to see whether an investigational medication is effective and well-tolerated in patients who received their Parkinson’s disease diagnosis at least five years ago and whose motor (movement) symptoms change significantly over the course of the day.
You may be able to participate in the ATLANTIS Study if you:
• Are between 35 and 80 years of age
• Have been diagnosed with Parkinson’s disease 5 or more years ago
• Are experiencing daily motor fluctuations (at least 2 hours in total of “OFF” time every day when Parkinson’s disease symptoms return after the medication has worn off)
• Are currently receiving treatment with levodopa (with or without additional therapies for Parkinson’s disease)
• Are willing to complete a 3-day symptom diary at four time points during the study
• Have not had brain surgery for PD (including deep brain stimulation, thalamus surgery, and experimental cell therapy or gene therapy)
• Are not using parenteral PD medication (medication that is infused or injected like duopa/duodopa or apomorphine)
• Do not have a diagnosis of dementia, other forms of important cognitive dysfunction, epilepsy or another seizure disorder
(There are additional criteria that need to be met, which the study team at Vaught Neurology will discuss with you.)
For further information about the ATLANTIS Study, please visit the website or call our office at 304-252-4222.
